Docetaxel + cyclophosphamide

Docetaxel + cyclophosphamide has been studied in 1 paper since 2018: 1 observational study in people. The newest story, Nov 9, 2026: “Human gene variant linked to chronic inflammation in older mice”.

Intervention

1 paper studies it9 more mention it1 findingUpdated Oct 22, 2018

PubChem PubChem ChEBI ChEBI

See all 10 papers on docetaxel + cyclophosphamide

At a glance

The findings reach people, from one lab or study. 1 lab in 1 country.

“all miRNAs showed moderate fluctuations during the study course with no significant differences between groups”

1 lab in 1 country

Funders: Fonds voor Wetenschappelijk Onderzoek-Vlaanderen and 2 more

Humans1

What did studies of docetaxel + cyclophosphamide find?

Studies of docetaxel + cyclophosphamide measured one outcome, age-related miRNAs.

Age-related miRNAs

no changein humans1

1 study

Docetaxel + cyclophosphamide showed no clear effect on age-related miRNAs in humans (chemotherapy group compared with control group without chemotherapy).
“all miRNAs showed moderate fluctuations during the study course with no significant differences between groups”
Human trialchemotherapy group compared with control group without chemotherapyserum1 yearfemales
Age-related microRNAs in older breast cancer patients: biomarker potential and evolution during adjuvant chemotherapy
BMC cancerOct 22, 2018

Latest

2 papers in 12 months

BMC CancerOct 22

Age-related microRNAs in older breast cancer patients: biomarker potential and evolution during adjuvant chemotherapy

Study of 46 peopleBreast cancer

Paper

Brain SciencesJul 28

Chemotherapy-Induced Brain Damage: Mechanisms and Insights from Rodent Models

ReviewMechanisms

Paper

The American Journal of PathologyJun 11

Human gene variant linked to chronic inflammation in older mice

An experiment in 14- to 16-month-old mice linked a human gene variant to weaker repair-related responses two weeks after chemotherapy.An experiment in 14- to 16-month-old mice linked a human gene variant to weaker repair-related responses two weeks after chemotherapy.

Mouse studyInflammation